| D05700 | |
| D number | D05700 |
| Classification | Drug |
| Name | Ranolazine (USAN/INN); Ranexa (TN) |
| Component | - |
| Formula | C24H33N3O4 |
| Exact mass | 427.2471 |
| Mol weight | 427.5365 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cyp inhibitor DG01522 CYP3A4 inhibitor Transporter substrate DG01665 P-glycoprotein substrate |
| Remark | ATC code: C01EB18 Chemical group: DG00247 |
| Activity | - |
| Disease | - |
| Comment | Treatment of chronic angina |
| Target | - |
| Metabolism | Transporter: ABCB1 [HSA:5243] |
| Interaction | CYP inhibition: CYP3A [HSA:1576 1577 1551] Transporter inhibition: ABCB1 [HSA:5243] |
| Other DBs | CAS: 95635-55-5 PubChem: 47207361 ChEBI: 87681 ChEMBL: CHEMBL1404 DrugBank: DB00243 LigandBox: D05700 NIKKAJI: J507.863F |
| KCF data | - |